IndexIQ Launches New ESG Core Plus Bond ETF “ESGB” in Partnership with MacKay Shields Jun 29, 2021 11:06AM
New York Life Investments and American Heart Association Introduce Thematic ESG ETF Focused on Health and Wellbeing Feb 1, 2021 09:15AM
Bioengineered Organ Implant Developer HART Names Accomplished Biotechnology Executive Dr. Blaine McKee to its Board Mar 10, 2016 11:06AM
HART Appoints Laura Mondano as Vice President of Regulatory Affairs To Lead HART's 2016 IND Submission For its Bioengineered Organ Implant Solutions Mar 2, 2016 04:26PM
Bioengineered Organ Implant Developer HART to Webcast BIO CEO Conference Presentation Tues., Feb. 9th at 8:00 am EST Feb 3, 2016 01:34PM


Feb 1, 2016 03:58PM Bioengineered Organ Implant Developer HART to Webcast Source Capital Disruptive Growth & Healthcare Conference Presentation Wed., Feb. 10th at 3:30 pm EST
Jan 7, 2016 04:15PM HART and Mayo Clinic Confirm Dates for Collaborative Large-Animal Bioengineered Organ Implant Surgeries
Dec 30, 2015 09:00AM Bioengineered Organ Implant Developer HART to Webcast Biotech Showcase™ Presentation Monday, Jan. 11 at 2:00 pm PT
Dec 15, 2015 04:58PM Harvard Apparatus (HART) Enters $15M Common Stock Purchase Facility with Aspire Capital
Dec 15, 2015 04:56PM HART Secures Common Stock Purchase Facility with Aspire Capital
Dec 8, 2015 11:54AM HART's CMO Dr. Saverio La Francesca to moderate panel on "Regenerative Engineering and Bio-Materials" at World Stem Cell Summit Saturday, Dec. 12
Dec 3, 2015 12:16PM Bioengineered Organ Implant Company HART to Present at RegMed Capital Conference in Atlanta, Friday Dec. 11 at 9:00 am ET
Nov 25, 2015 01:56PM Bioengineered Organ Implant Company HART to Webcast LD Micro Presentation in Los Angeles, Tues. Dec. 1st at 2:30 pm PT
Aug 10, 2015 08:30AM Harvard Apparatus Regenerative Technology, Connecticut Children’s Medical Center Collaborate to Develop Bioengineered Pediatric Esophageal Solutions